Brown Advisory Securities LLC Sells 76 Shares of Walgreens Boots Alliance, Inc. (WBA)
Brown Advisory Securities LLC reduced its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,302 shares of the pharmacy operator’s stock after selling 76 shares during the period. Brown Advisory Securities LLC’s holdings in Walgreens Boots Alliance were worth $357,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Meiji Yasuda Asset Management Co Ltd. increased its stake in shares of Walgreens Boots Alliance by 0.5% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 57,412 shares of the pharmacy operator’s stock valued at $4,768,000 after buying an additional 286 shares in the last quarter. Marshall Wace North America L.P. acquired a new stake in shares of Walgreens Boots Alliance during the first quarter valued at approximately $1,744,000. Guardian Life Insurance Co. of America increased its stake in shares of Walgreens Boots Alliance by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 3,301 shares of the pharmacy operator’s stock valued at $274,000 after buying an additional 22 shares in the last quarter. MARSHALL WACE ASIA Ltd acquired a new stake in shares of Walgreens Boots Alliance during the first quarter valued at approximately $2,491,000. Finally, Putnam FL Investment Management Co. increased its stake in shares of Walgreens Boots Alliance by 1,037.3% in the first quarter. Putnam FL Investment Management Co. now owns 74,860 shares of the pharmacy operator’s stock valued at $6,217,000 after buying an additional 68,278 shares in the last quarter. Institutional investors own 61.17% of the company’s stock.
Walgreens Boots Alliance, Inc. (WBA) traded up 1.22% on Friday, reaching $80.72. The company had a trading volume of 3,992,347 shares. The firm has a market capitalization of $86.38 billion, a P/E ratio of 20.38 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $89.69. The company’s 50-day moving average price is $79.08 and its 200 day moving average price is $82.30.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the company posted $1.18 EPS. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post $5.01 EPS for the current year.
Walgreens Boots Alliance announced that its Board of Directors has approved a stock buyback program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to purchase up to 5.9% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, August 16th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 1.98%. Walgreens Boots Alliance’s dividend payout ratio is 37.78%.
COPYRIGHT VIOLATION WARNING: This story was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://theolympiareport.com/2017/08/12/brown-advisory-securities-llc-sells-76-shares-of-walgreens-boots-alliance-inc-wba.html.
Several analysts have commented on the company. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 3rd. Needham & Company LLC set a $94.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Monday, July 17th. Credit Suisse Group reiterated a “buy” rating and set a $97.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, July 13th. Leerink Swann set a $86.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Friday, July 7th. Finally, Citigroup Inc. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the company. Walgreens Boots Alliance presently has an average rating of “Buy” and an average target price of $90.69.
In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now directly owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 13.50% of the stock is owned by corporate insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.